Menu

rss
Evid Based Nurs 12:45 doi:10.1136/ebn.12.2.45
  • Treatment

Review: weight-reducing agents improve glycaemic control and reduce progression to diabetes

S Czernichow

Dr S Czernichow, Unite de Recherche en Nutrition Humaine, Bobigny, France; s.czernichow@uren.smbh.univ-paris13.fr

QUESTION

How do weight-reducing agents affect glycaemic parameters and risk of type 2 diabetes in predisposed individuals?

REVIEW SCOPE

Included studies were randomised, double-blind, placebo controlled trials (RCTs) that evaluated the effects of weight-reducing agents (eg, orlistat, sibutramine, and rimonabant) on fasting glucose or glycated haemoglobin (HbA1c) concentrations and had a duration of ⩾1 year. Studies of mixed populations were excluded. Outcomes included weight loss, fasting glucose and HbA1c concentrations, and diabetes.

REVIEW METHODS

Medline was searched from …

[Full text of this article]

This Article

  1. Extract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Social bookmarking

EBN Twitter Journal Club

The club runs like other journal discussion groups, except that the article and questions are posted on this blog and the discussion about the article happens on Twitter.

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.